MAROZZI, ANNA
MAROZZI, ANNA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Therapeutic potential of HDAC8 Inhibition and SIRT1 activation in Duchenne muscular dystrophy
2025 S. Carbone, A. Brix, L. Lociuro, O. Gjana, L. Belleri, M. Schiavone, A. Marozzi, F. Del Bene, C. De Palma, A. Pistocchi, A. Pezzotta
Therapeutic potential of HDAC8 Inhibition and SIRT1 activation in Duchenne muscular dystrophy
2025 S. Carbone, A. Brix, L. Lociuro, O. Gjana, L. Belleri, M. Schiavone, A. Marozzi, F. Del Bene, C. De Palma, A. Pistocchi, A. Pezzotta
HDAC8 and HDAC6 combined inhibition: a new frontier in glioblastoma treatment
2025 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Pezzotta, A. Marozzi, G. Carullo, L. Sicuro, L. Mollica, L. Bello, G. Campiani, P. Viani, M. Caterina Mione, A. Pistocchi
HDAC6 and HDAC8 inhibition enhances the efficacy of Temozolomide by rewiring sphingolipid metabolism and glioma cell fate
2025 I. Tagliabue, L. Brioschi, G. Galassi, S. Carbone, A. Pezzotta, A. Marozzi, L. Mollica, L. Sicuro, L. Bello, G. Campiani, G. Carullo, M. Caterina Mione, A. Pistocchi, P. Viani
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2025 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
HDAC8 AND HDAC6 COMBINED INHIBITION: A NEW FRONTIER IN GLIOBLASTOMA TREATMENT
2025 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, D. Giana, A. Pezzotta, A. Marozzi, G. Carullo, L. Sicuro, L. Mollica, L. Bello, G. Campiani, P. Viani, M.C. Mione, A. Pistocchi
Combination therapy targeting HDAC8 and SIRT1 improves muscle integrity in a dmd zebrafish model
2025 S. Carbone, A. Brix, L. Lociuro, O. Gjana, L. Belleri, M. Schiavone, A. Marozzi, F. Del Bene, C. De Palma, A. Pezzotta, A. Pistocchi
ADA2 regulates inflammation and hematopoietic stem cells emergence via the A2bR pathway in zebrafish
2024 A. Brix, L. Belleri, E. Pettinato, M. Mazzola, M. Zoccolillo, A. Marozzi, R. Monteiro, F. Del Bene, A. Mortellaro, A. Pistocchi
Hedgehog and HDAC6 in cancers: dissection of dysregulated biological mechanisms and potential therapeutic treatments
2024 A. Pezzotta, L. Brioschi, S. Carbone, G. Galassi, L. Sicuro, M. Alcalay, G. Carullo, G. Campiani, L. Mollica, A. Marozzi, M. Mione, P. Viani, A. Pistocchi
ADA2 regulates inflammation and hematopoietic stem cell emergence via the A2bR pathway in zebrafish
2024 A. Brix, L. Belleri, A. Pezzotta, E. Pettinato, M. Mazzola, M. Zoccolillo, A. Marozzi, R. Monteiro, F. Del Bene, A. Mortellaro, A. Pistocchi
Improving the effects of HDAC8 inhibition by combining the activation of SIRT1 in a zebrafish model of Duchenne muscular dystrophy
2024 A. Pezzotta, S. Carbone, M. Cafora, A. Brix, L. Belleri, M. Giovarelli, L. Lociuro, M. Schiavone, A. Marozzi, F. Del Bene, C. De Palma, A. Pistocchi
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis
2023 A. Pezzotta, I. Gentile, D. Genovese, M. Totaro, C. Battaglia, A. Leung, M. Fumagalli, M. Parma, G. Cazzaniga, G. Fazio, M. Alcalaym, A. Marozzi, A. Pistocchi
Combined Inhibition of Hedgehog and HDAC6: In Vitro and In Vivo Studies Reveal a New Role for Lysosomal Stress in Reducing Glioblastoma Cell Viability
2023 A. Pezzotta, L. Brioschi, S. Carbone, B. Mazzoleni, V. Bontempi, F. Monastra, L. Mauri, A. Marozzi, M. Mione, A. Pistocchi, P. Viani
Targeting Hedgehog and HDAC6 in acute myeloid leukemia in in vitro and zebrafish models
2022 A. Pezzotta, I. Gentile, D. Genovese, M. Totaro, C. Battaglia, A. Leung, M. Fumagalli, M. Parma, M. Alcalay, A. Marozzi, A. Pistocchi
HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis
2022 A. Pezzotta, I. Gentile, D. Genovese, M.G. Totaro, C. Battaglia, A.Y. Leung, M. Fumagalli, M. Parma, G. Cazzaniga, G. Fazio, M. Alcalay, A. Marozzi, A. Pistocchi
Generation of a triadin KnockOut syndrome zebrafish model
2021 V.M. Vecchi, M. Spreafico, A. Brix, A. Santoni, S. Sala, A. Pistocchi, A. Marozzi, C. Di Resta
HDAC8 promotes hematopoietic stem and progenitor cells proliferation with implications in acute myeloid leukemia
2021 M. Spreafico, A. Gruszka, D. Valli, M. Mazzola, G. Deflorian, A. Quintè, M. Totaro, C. Battaglia, M. Alcalay, A. Marozzi, A. Pistocchi
Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy
2021 M. Spreafico, M. Cafora, C. Bragato, D. Capitanio, F. Marasca, B. Bodega, C. De Palma, M. Mora, C. Gelfi, A. Marozzi, A. Pistocchi
Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency
2021 I. Bestetti, C. Barbieri, A. Sironi, V. Specchia, S.A. Yatsenko, M.D. De Donno, C. Caslini, D. Gentilini, M. Crippa, L. Larizza, A. Marozzi, A. Rajkovic, D. Toniolo, M.P. Bozzetti, P. Finelli
Targeted next-generation sequencing indicates a frequent oligogenic involvement in primary ovarian insufficiency onset
2021 R. Rossetti, S. Moleri, F. Guizzardi, D. Gentilini, L. Libera, A. Marozzi, C. Moretti, F. Brancati, M. Bonomi, L. Persani